Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Nat Commun ; 14(1): 6911, 2023 10 30.
Article in English | MEDLINE | ID: mdl-37903797

ABSTRACT

Axon degeneration and functional decline in myelin diseases are often attributed to loss of myelin but their relation is not fully understood. Perturbed myelinating glia can instigate chronic neuroinflammation and contribute to demyelination and axonal damage. Here we study mice with distinct defects in the proteolipid protein 1 gene that develop axonal damage which is driven by cytotoxic T cells targeting myelinating oligodendrocytes. We show that persistent ensheathment with perturbed myelin poses a risk for axon degeneration, neuron loss, and behavioral decline. We demonstrate that CD8+ T cell-driven axonal damage is less likely to progress towards degeneration when axons are efficiently demyelinated by activated microglia. Mechanistically, we show that cytotoxic T cell effector molecules induce cytoskeletal alterations within myelinating glia and aberrant actomyosin constriction of axons at paranodal domains. Our study identifies detrimental axon-glia-immune interactions which promote neurodegeneration and possible therapeutic targets for disorders associated with myelin defects and neuroinflammation.


Subject(s)
Demyelinating Diseases , Microglia , Animals , Mice , Axons/metabolism , CD8-Positive T-Lymphocytes , Demyelinating Diseases/metabolism , Myelin Sheath/metabolism , Neuroinflammatory Diseases
2.
Autoimmunity ; 51(4): 147-151, 2018 06.
Article in English | MEDLINE | ID: mdl-29996671

ABSTRACT

Multiple sclerosis (MS) is a demyelinating disease of the central nervous system causing axonal injury, neuronal loss, and atrophy of the central nervous system leading to permanent neurological and clinical disability. Presence of mutations in M9 domain of HNRNPA1 and detection of autoantibodies against this domain in HNRNPA1 qualifies it as a strong candidate for causing MS. These two aspects indicate the presence of a facilitator in associating them. Varicella zoster virus (VZV), known to cause chicken pox infection in humans, is a significant contender in sensitizing the infected people towards MS. Reactivation of latent herpes viruses by other infectious agents and cross-recognition of common viral antigens with antigens found in the myelin sheath induces molecular mimicry or superantigens. Mutations in HNRNPA1 cause mislocalization to the cytoplasm, and co-localize with stress granules (SG) causing cellular apoptosis, this creates the first step toward MS pathogenesis. Mutant HNRNPA1 accumulates in SG allowing the cells to display peptides of HNRNPA1 on surfaces of major histocompatibility complex (MHC) I triggering a cascade of immune reactions. Since glycoprotein E (gE) of VZV shares >62% amino acids sequence similarity with Prion-like domain (PrLD) of HNRNPA1, signifying the reason behind autoantibodies against M9 and PrLD of HNRNPA1. This review attempts to delineate the interactions of VZV, gE of VZV, with M9 domain and PrLD of HNRNPA1 in a step-by-step process. This supports the tripartite model that an environmental trigger in genetically susceptible individuals causes an autoimmune response to self-CNS antigens that result in the pathology observed in the brain and spinal cord of MS patients.


Subject(s)
Central Nervous System/immunology , Chickenpox/immunology , Chickenpox/virology , Herpesvirus 3, Human/immunology , Heterogeneous Nuclear Ribonucleoprotein A1/immunology , Multiple Sclerosis , Mutation , Viral Envelope Proteins/immunology , Animals , Antigens, Viral/immunology , Apoptosis/genetics , Apoptosis/immunology , Autoantibodies/genetics , Autoantibodies/immunology , Axons/immunology , Axons/pathology , Central Nervous System/pathology , Central Nervous System/virology , Chickenpox/pathology , Herpesvirus 3, Human/pathogenicity , Heterogeneous Nuclear Ribonucleoprotein A1/genetics , Histocompatibility Antigens Class I/immunology , Humans , Models, Immunological , Molecular Mimicry/genetics , Molecular Mimicry/immunology , Multiple Sclerosis/genetics , Multiple Sclerosis/immunology , Multiple Sclerosis/pathology , Multiple Sclerosis/virology , Myelin Sheath/immunology , Myelin Sheath/pathology , Myelin Sheath/virology , Protein Domains , Superantigens/genetics , Superantigens/immunology
3.
Mult Scler Relat Disord ; 22: 153-156, 2018 May.
Article in English | MEDLINE | ID: mdl-29729524

ABSTRACT

OBJECTIVES: To identify Damaging mutations in microRNAs (miRNAs) and 3' untranslated regions (UTRs) of target genes to establish Multiple sclerosis (MS) disease pathway. METHODS: Female aged 16, with Relapsing Remitting Multiple sclerosis (RRMS) was reported with initial symptoms of blurred vision, severe immobility, upper and lower limb numbness and backache. Whole Exome Sequencing (WES) and disease pathway analysis was performed to identify mutations in miRNAs and UTRs. RESULTS: We identified Deleterious/Damaging multibase mutations in MIR8485 and NRXN1. miR-8485 was found carrying frameshift homozygous deletion of bases CA, while NRXN1 was found carrying nonframeshift homozygous substitution of bases CT to TC in exon 8 replacing Serine with Leucine. CONCLUSIONS: Mutations in miR-8485 and NRXN1 was found to alter calcium homeostasis and NRXN1/NLGN1 cell adhesion molecule binding affinities. The miR-8485 mutation leads to overexpression of NRXN1 altering pre-synaptic Ca2+ homeostasis, inducing neurodegeneration.


Subject(s)
Cell Adhesion Molecules, Neuronal/genetics , MicroRNAs/genetics , Multiple Sclerosis, Relapsing-Remitting/genetics , Nerve Degeneration/genetics , Nerve Tissue Proteins/genetics , Adolescent , Calcium/metabolism , Calcium-Binding Proteins , Cell Adhesion Molecules, Neuronal/metabolism , Female , Homeostasis/genetics , Homeostasis/physiology , Humans , MicroRNAs/metabolism , Multiple Sclerosis, Relapsing-Remitting/metabolism , Multiple Sclerosis, Relapsing-Remitting/pathology , Mutation , Nerve Degeneration/metabolism , Nerve Degeneration/pathology , Nerve Tissue Proteins/metabolism , Neural Cell Adhesion Molecules , Synapses/genetics , Synapses/metabolism , Synapses/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...